Impact of Infectious Diseases Society of America/Pediatric Infectious Diseases Society guidelines on treatment of community-acquired pneumonia in hospitalized children.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 24399088.
- Also identified by DOI 10.1093/cid/ciu013 and PMC identifier 6276918.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We examined the impact of the Pediatric Infectious Diseases Society/Infectious Diseases Society of America guidelines that recommend ampicillin or amoxicillin for children hospitalized with community-acquired pneumonia. Prescribing of ampicillin/amoxicillin increased following guideline publication, but remains low. Cephalosporin and macrolide prescribing decreased but remains common. Further studies exploring outcomes of and reasons for compliance with guidelines are warranted.
Medical subject headings
- Anti-Bacterial Agents
- Community-Acquired Infections
- Hospitalization
- Pneumonia